These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6178008)

  • 1. Low-dose bleomycin lung.
    Wilson KS; Worth A; Richards AG; Ford HS
    Med Pediatr Oncol; 1982; 10(3):283-8. PubMed ID: 6178008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity.
    Richman SD; Levenson SM; Bunn PA; Flinn GS; Johnston GS; DeVita VT
    Cancer; 1975 Dec; 36(6):1966-72. PubMed ID: 54210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary complications of chemotherapy regimens containing bleomycin.
    Balikian JP; Jochelson MS; Bauer KA; Skarkin AT; Garnick MB; Canellos GP; Smith EH
    AJR Am J Roentgenol; 1982 Sep; 139(3):455-61. PubMed ID: 6180618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804.
    Ginsberg SJ; Crooke ST; Bloomfield CD; Peterson B; Kennedy BJ; Blom J; Ellison RR; Pajak TF; Gottlieb AJ
    Cancer; 1982 Apr; 49(7):1346-52. PubMed ID: 6174203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary alterations in Hodgkin lymphoma].
    Jóna Á; Illés Á; Szemes K; Miltényi Z
    Orv Hetil; 2016 Jan; 157(5):163-73. PubMed ID: 26801361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
    Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
    Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
    Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
    Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible interstitial pneumonitis associated with low dose bleomycin.
    O'Neill TJ; Kardinal CG; Tierney LM
    Chest; 1975 Aug; 68(2):265-7. PubMed ID: 50163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening bleomycin pulmonary toxicity with ultimate reversibility.
    Hartmann LC; Frytak S; Richardson RL; Coles DT; Cupps RE
    Chest; 1990 Aug; 98(2):497-9. PubMed ID: 1695873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin-related lung damage: CT evidence.
    Bellamy EA; Husband JE; Blaquiere RM; Law MR
    Radiology; 1985 Jul; 156(1):155-8. PubMed ID: 2408293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
    Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
    Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-67-citrate uptake in a case of acne vulgaris.
    Kipper MS; Taylor A; Ashburn WL
    Clin Nucl Med; 1981 Sep; 6(9):409-10. PubMed ID: 6168425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium-111 bleomycin tumor scanning in lymphoma.
    Jones SE; Lilien DL; O'Mara RE; Durie BG; Salmon SE
    Med Pediatr Oncol; 1975; 1(1):11-21. PubMed ID: 60694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal pulmonary fibrosis from low-dose bleomycin therapy.
    Bechard DE; Fairman RP; DeBlois GG; Via CT
    South Med J; 1987 May; 80(5):646-9. PubMed ID: 2437659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 67Ga-citrate, 111In-bleomycin and 99mTc-citrate in the evaluation of pulmonary lesions.
    Apostolidis P; Kostaki P; Hatzigeorgiou N; Skambardonis N; Giavroglou J; Salem N
    Eur J Nucl Med; 1980; 5(1):57-61. PubMed ID: 6155268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pulmonary changes of bleomycin toxicity.
    Horowitz AL; Friedman M; Smith J; Yagoda A; LaMonte C; Watson RC
    Radiology; 1973 Jan; 106(1):65-8. PubMed ID: 4118845
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleomycin-induced pulmonary nodules: a variant of bleomycin pulmonary toxicity.
    Zucker PK; Khouri NF; Rosenshein NB
    Gynecol Oncol; 1987 Nov; 28(3):284-91. PubMed ID: 2445636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular bleomycin toxicity.
    Cohen MB; Austin JH; Smith-Vaniz A; Lutzky J; Grimes MM
    Am J Clin Pathol; 1989 Jul; 92(1):101-4. PubMed ID: 2473646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bleomycin-induced pulmonary infiltrations in the treatment of testicular cancer].
    Clemm C; Hartenstein R; Mayr B; Wilmanns W
    Klin Wochenschr; 1984 Feb; 62(3):138-44. PubMed ID: 6200644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.